Browse EX-10 agreements

CONFIDENTIAL – J. Wyrick CONFIDENTIAL - STARZ EXECUTIVE EMPLOYMENT AGREEMENT EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”), made effective as of October 1, 2026, is entered into by and between Starz Entertainment, LLC, a Colorado limited liability company (“Employer”), and Jason Wyrick (“Executive”). Employer desires to employ Executive, and Executive desires to be employed with Employer, under the terms and conditions set forth herein. Certain capitalized terms used in this Agreement have the meanings set forth in Section 9. NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: Section 1. Employment; Term; Duties 1.1. Employment. Upon the terms and conditions hereinafter set forth, Employer hereby employs Executive, and Executive hereby accepts employment, as Executive Vice President, Technology. 1.2. Term. The term of this Agreement will begin October 1, 2026 (“Effective Date”

…

Exhibit 10.1 Lamb Weston Proprietary 5 October 2026 ______________________ TRANSITION AND SEPARATION AGREE- MENT ______________________ Between (1) Lamb Weston B.V. and (2) Marc Schroeder

---

2/11 Lamb Weston Proprietary This Transition and Separation Agreement (the “Termination Agreement”) is concluded on 5 October 2026 between the following parties: THE UNDERSIGNED: 1. Lamb Weston B.V., a private company with limited liability (besloten ven- nootschap) incorporated under the laws of the Netherlands and registered under company number 22026293 in the Register of the Dutch Chamber of Com- merce, having its registered office at Topaasstraat 54, 4817 HW Breda, the Netherlands (“Lamb Weston”), duly represented by Mr. G. Jansen. 2. Mr. M.P.J.H. Schroeder, residing at Julianaweg 10, 2243 HT Wassenaar, the Netherlands (“Mr. Schroeder”). Lamb Weston and Mr. Schroeder may be referred to hereinafter individually as a “Party” and jointly as the “Parties”. BACKGROUND: A. Mr. Schroeder has been employed by (the pr

…

***Execution version ***

**G-INFRA LP, **

as Borrower

Up to $50,000,000

**SENIOR CREDIT AGREEMENT **

SOCIÉTÉ GÉNÉRALE,

as Administrative Agent, Calculation Agent and Lead Arranger

September 30, 2026

---

**TABLE OF CONTENTS **

				Page
SECTION 1.		DEFINITIONS			1
1.1		Defined Terms			1

…

VisionWave Holdings, Inc.

300 Delaware Ave., Suite 210 #301

Wilmington, Delaware 19801

October 2, 2026

Eric T. Shuss

[***]

[***]

Re: Amendment No. 1 to Employment Agreement – Base Salary

Dear Mr. Shuss:

This letter agreement (this “Amendment”) amends the Employment Agreement dated as of March 13, 2026 (the “Employment Agreement”), by and between VisionWave Holdings, Inc., a Delaware corporation (the “Company”), and you (“Executive”). Capitalized terms used but not defined in this Amendment have the meanings given to them in the Employment Agreement.

WHEREAS, Executive has served as Chief Operating Officer of the Company since March 13, 2026, at an annual Base Salary of $120,000, with Section 3.1 of the Employment Agreement providing for an increase in Base Salary to an annual rate of $240,000 upon the Company achieving $3,000,000 in revenue during any ninety (90) day period (the “Revenue Condition”);

WHEREAS, the Revenue Condition has not been satisfied as of the date of this Amendment;

…

**2026 EMPLOYEE STOCK PURCHASE PLAN **

1

---

**QUINCE THERAPEUTICS, INC. **

**2026 EMPLOYEE STOCK PURCHASE PLAN **

**ADOPTED BY THE BOARD OF DIRECTORS: July 29, 2026 **

**APPROVED BY THE STOCKHOLDERS: October 6, 2026 **

1.	**GENERAL; PURPOSE. **

(a) The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible Employees that do not meet the requirements of an Employee Stock Purchase Plan.

…

**2026 EQUITY INCENTIVE PLAN **

1

---

**QUINCE THERAPEUTICS, INC. **

**2026 EQUITY INCENTIVE PLAN **

**ADOPTED BY THE BOARD OF DIRECTORS: July 29, 2026 **

**APPROVED BY THE STOCKHOLDERS: October 6, 2026 **

1.	**GENERAL. **

(a) Successor to Prior Plans. The Plan is the successor to the Prior Plans. As of the Effective Date, (i) no additional awards may be granted under the Prior Plans; and (ii) all outstanding awards granted under a Prior Plan will remain subject to the terms of such Prior Plan. All Awards granted under this Plan will be subject to the terms of this Plan.

(b) Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

…

ASSIGNMENT, JOINDER, AND AMENDMENT NO. 1

TO

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

This Assignment, Joinder, and Amendment No. 1 to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of September 30, 2026 (the “Amendment Date”), by and among Nuo Therapeutics, Inc., a Delaware corporation (the “Company”), and each person named on Schedule A to this Amendment (individually, “Lender” and collectively, “Lenders”) as an amendment to the Amended and Restated Loan and Security Agreement (the “Existing Agreement”) dated as of May 29, 2026 by and among the Company and the lenders named on Schedule A to the Existing Agreement (individually, “Existing Lender” and collectively, “Existing Lenders”).

Capitalized terms not otherwise defined in this Amendment shall have the meanings set forth in the Existing Agreement. References in this Amendment to the “Agreement” mean the Existing Agreement as amended by this Amendment.

…

ACTUATE THERAPEUTICS, INC.

1751 River Run, Suite 400
Fort Worth, Texas 76107

** **

October 2, 2026

Bios Partners, L.P,

1751 River Run, Suite 400

Fort Worth, TX 76107

Atten:	Aaron Glenn Louis Fletcher, Ph.D.,
	Managing Partner

Dear Dr. Fletcher:

We are writing with respect to the shares of common stock of Actuate Therapeutics, Inc., a Delaware corporation (the “Company”), beneficially owned by you and the various entities (“Bios Entities”) managed by Bios Partners, L.P. and that appear above your signature block.

…

ACTUATE THERAPEUTICS, INC.

1751 River Run, Suite 400
Fort Worth, Texas 76107

** **

October 2, 2026

Kairos Venture Investments, LLC

9440 S. Santa Monica Blvd, Ste 710

Beverly Hills, CA 90210

Attn: Todd Thomson, Chief Financial Officer

Dear Mr. Thomson:

We are writing with respect to the shares of common stock of Actuate Therapeutics, Inc., a Delaware corporation (the “Company”), beneficially owned by you and the various entities (“Kairos Entities”) managed by Kairos Venture Investments, LLC and that appear above your signature block.

…

**THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE MAKER THAT SUCH REGISTRATION IS NOT REQUIRED. **

**CONVERTIBLE PROMISSORY NOTE **

Principal Amount: US$1,550,000.00

Dated: September 30, 2026

…

Execution Version

FIRST AMENDMENT TO FINANCIAL ASSISTANCE AGREEMENT

This **FIRST AMENDMENT TO FINANCIAL ASSISTANCE AGREEMENT **(this “Amendment”) is entered into as of September 30, 2026, by and among (i) Berkshire Hathaway Specialty Insurance Company (“Berkshire”), Zurich American Insurance Company, Hartford Fire Insurance Company, Euler Hermes North America, Markel Insurance Company, Western Surety Company, Federal Insurance Company (collectively referred to as “Sureties” and each as “Surety”), (ii) Southland Holdings, LLC (“Southland”), Southland Holdings, Inc., Southland RE Properties LLC, Southland Contracting, Inc., Heritage Materials, LLC, Southland Mole of Canada, Ltd., Johnson Bros. Corporation, a Southland Company, Oscar Renda Contracting, Inc., Oscar Renda Contracting of Canada, Inc., Renda Pacific LLC, Mole Constructors, Inc., American Bridge Holding Company, American Bridge Company, American Bridge Manufacturing Company, American Dock & Transfer Company, American Bridge International Corporation, American Bridge Canada Company, Renda

…

Execution Version $2,400,000,000 CREDIT AGREEMENT Dated as of October 5, 2026, among COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION, as the Borrower, COGNIZANT WORLDWIDE LIMITED, as a Designated Borrower, The Additional Designated Borrowers from Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, The Other Lenders Party Hereto, BANK OF AMERICA, N.A., BNP PARIBAS SECURITIES CORP., TD BANK, N.A. and TRUIST BANK as Syndication Agents, and BANK OF CHINA, BANK OF NOVA SCOTIA, CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, HSBC BANK USA, N.A., PNC BANK, NATIONAL ASSOCIATION, STANDARD CHARTERED BANK and U.S. BANK NATIONAL ASSOCIATION as Documentation Agents and AGRICULTURAL BANK OF CHINA LIMITED, NEW YORK BRANCH, BANCO SANTANDER, S.A., NEW YORK BRANCH, GOLDMAN SACHS BANK USA, THE BANK OF NEW YORK MELLON, and MUFG BANK, LTD. as Senior Managing Agents JPMORGAN CHASE BANK, N.A., BANK OF AMERICA, N.A., BNP PARIBAS SECURITIES CORP., TD BANK, N.A. and TRUIST SECURITIES, INC. as Joint Lead Arrangers and Joint Bookrunners

---

…